<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">epilepsia</journal-id><journal-title-group><journal-title xml:lang="en">Epilepsy and paroxysmal conditions</journal-title><trans-title-group xml:lang="ru"><trans-title>Эпилепсия и пароксизмальные состояния</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2077-8333</issn><issn pub-type="epub">2311-4088</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">epilepsia-26</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group></article-categories><title-group><article-title>MODERN TREATMENT OPTIONS FOR DRUG-RESISTANT EPILEPSY IN CHILDREN</article-title><trans-title-group xml:lang="ru"><trans-title>СОВРЕМЕННЫЕ ВОЗМОЖНОСТИ ЛЕЧЕНИЯ ФАРМАКОРЕЗИСТЕНТНОЙ ЭПИЛЕПСИИ У ДЕТЕЙ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Айвазян</surname><given-names>С. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Aivazyan</surname><given-names>S. O.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лукьянова</surname><given-names>Е. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Lukyanova</surname><given-names>E. G.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ширяев</surname><given-names>Ю. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Shiryaev</surname><given-names>Yu. S.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-практический центр медицинской помощи детям Департамента здравоохранения г. Москвы; Медицинский центр «Невромед», Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Scientifically-practical centre of medical aid to children PHD of Moscow; Medical center «Neuromed», Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Научно-практический центр медицинской помощи детям Департамента здравоохранения г. Москвы</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Scientifically-practical centre of medical aid to children PHD of Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>01</day><month>06</month><year>2016</year></pub-date><volume>6</volume><issue>1</issue><fpage>34</fpage><lpage>43</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Aivazyan S.O., Lukyanova E.G., Shiryaev Y.S., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Айвазян С.О., Лукьянова Е.Г., Ширяев Ю.С.</copyright-holder><copyright-holder xml:lang="en">Aivazyan S.O., Lukyanova E.G., Shiryaev Y.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.epilepsia.su/jour/article/view/26">https://www.epilepsia.su/jour/article/view/26</self-uri><abstract><p>Abstract: we present the experience of applying the methods of non-drug treatment drug-resistant epilepsy in children. These include surgery, ketogenic diet and chronic vagus nerve stimulation (VNS therapy). Methods. We observed 118 patients with refractory epilepsy. As a result of a comprehensive survey 46 patients became candidates for surgical treatment, VNS stimulator implanted in 17 patients, and the ketogenic diet recommended for 50 patients. Results. Surgical treatment showed the highest efficiency: the complete elimination of seizures (100%) was observed in 28 (61%) patients, reducing the number of seizures of &gt;75% was observed in 1 (2%), &gt;50% in 5 (11%) and &lt;50 % in 12 (26%) patients. Efficiency of a ketogenic diet conceded to surgery: 100 % reduction of seizures observed in 9 (18%) patients, &gt;75% in 10 (20%), &gt;50 % in 4 (8%) and &lt;50% in 27 (54%) patients. VNS stimulation, as well as the ketogenic diet was less effective compared with surgical treatment: 100% effect was observed in 3 (17.5%) patients, reducing the seizures of &gt;75% in 2 (12%), &gt;50 % in 17 (15%) and &lt;50 % in 43 (38%) patients. Conclusions. The most effective and radical treatment of refractory epilepsy is surgery in comparing with the ketogenic diet and VNS stimulation. The overall efficiency of these treatments (seizure reducing more than 50%) was observed in 70 patients, representing 62% of the total. Thus, an integrated approach in the treatment of refractory epilepsy allows to achieve a positive effect in significant number of cases.</p></abstract><trans-abstract xml:lang="ru"><p>В работе представлен опыт применения методов немедикаментозного лечения фармакорезистентных эпилепсий у детей. К ним относятся хирургия, кетогенная диета и хроническая стимуляция блуждающего нерва (VNS терапия). Материал и методы. Под нашим наблюдением находилось 118 пациентов, страдающих рефрактерной эпилепсией. В результате проведенного комплексного обследования кандидатами на хирургическое лечение стали 46 пациентов, стимулятор n. vagus имплантирован 17 пациентам, а кетогенная диета рекомендована 50 пациентам. Результаты. Хирургическое лечение показало самую высокую эффективность: полная ликвидация приступов (100%) наблюдалась у 28 (61%) пациентов, сокращение числа приступов &gt;75% отмечалась у 1 (2%), &gt;50% – у 5 (11%) и &lt;50% – у 12 (26%) пациентов. Эффективность кетогенной диеты уступала хирургии: 100% сокращение приступов отмечалось у 9 (18%) пациентов, &gt;75% – у 10 (20%), &gt;50% – у 4 (8%) и &lt;50% – у 27 (54%) пациентов. VNS¬терапия, так же как и кетогенная диета, была менее эффективна в сравнении с хирургическим лечением: 100% эффект отмечался у 3 (17,5%) пациентов, сокращение количества приступов &gt;75% – у 2 (12%), &gt;50% – у 17 (15%) и &lt;50% – у 43 (38%) пациентов. Выводы. Наиболее эффективным и радикальным методом лечения рефрактерной эпилепсии является хирургия при сравнении с кетогенной диетой и VNS-терапией. Суммарная эффек¬тивность перечисленных методов лечения в виде сокращения количества приступов более чем на 50% отмечалась у 70 пациентов, что составило 62% от общего количества. Таким образом, применение комплексного подхода в лечении рефрактерной эпилепсии позволяет добиться положительного эффекта в значительном числе случаев.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>фармакорезистентная эпилепсия у детей</kwd><kwd>хирургическое лечение эпилепсии</kwd><kwd>кетогенная диета</kwd><kwd>стимуляция блуждающего нерва</kwd><kwd>VNS-терапия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>refractory epilepsy in children</kwd><kwd>surgical treatment of epilepsy</kwd><kwd>ktogenic diet</kwd><kwd>vagus nerve stimulation</kwd><kwd>VNS therapy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Усачева Е.Л., Айвазян С.О., Сорвачева Т.Н., Пырьева Е.А., Шорина М.Ю. Применение кетогенной диеты в лечении фармакорезистентных эпилепсий. Журная неврологии и психиатрии им. С.С. Корсакова.2004; 7: 29-34.</mixed-citation><mixed-citation xml:lang="en">Usacheva E.L., Ajvazjan S.O., Sorvacheva T.N., Pyr eva E.A., Shorina M.Ju. Primenenie ketogennoj diety v lechenii farmakorezis-tentnyh jepilepsij. Zhurnaja nevrologii i psihiatrii im. S.S. Korsakova. 2004; 7: 29-34. Alexopoulos A.V., Kotagal P., Loddenkemper T. et al. Long-term results with vagus nerve stimulation in children with pharmacore-sistant epilepsy. Seizure. 2006; 15: 491-503.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Amar A.P., Elder J.B., Apuzzo M.L.J. Vagal Nerve Stimulation for Seizures. Textbook of Stereotactic and Functional Neurosurgery. Ed. by A.M. Lozano, P.L. Gildenberg, R.R. Tasker. Springer. 2009; 2801-2822.</mixed-citation><mixed-citation xml:lang="en">Amar A.P., Elder J.B., Apuzzo M.L.J. Vagal Nerve Stimulation for Seizures. Textbook of Stereotactic and Functional Neurosurgery. Ed. by A.M. Lozano, P.L. Gildenberg, R.R. Tasker. Springer. 2009; 2801-2822.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Benifla M., Rutka J.T., Logan W., Donner E.J. Vagal nerve stimulation for refractory epilepsy in children: indications and experience at The Hospital for Sick Children. Childs Nerv. Syst. 2006; 22: 1018-1026.</mixed-citation><mixed-citation xml:lang="en">Benifla M., Rutka J.T., Logan W., Donner E.J. Vagal nerve stimulation for refractory epilepsy in children: indications and experience at The Hospital for Sick Children. Childs Nerv. Syst. 2006; 22: 1018-1026.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ben-Menachem E., Hellstrom K., Waldton C., Augustinsson L.E: Evaluation of refractory epilepsy treated with vagus nerve stimulation for up to 5 years. Neurology. 1999; 52: 1265-1267.</mixed-citation><mixed-citation xml:lang="en">Ben-Menachem E., Hellstrom K., Waldton C., Augustinsson L.E: Evaluation of refractory epilepsy treated with vagus nerve stimulation for up to 5 years. Neurology. 1999; 52: 1265-1267.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bough K.J., Rho Jong M. Anticonvulsant Mechanisms of the Ketogenic Diet. Epilepsia. 2007; 48 (1): 43-58.</mixed-citation><mixed-citation xml:lang="en">Bough K.J., Rho Jong M. Anticonvulsant Mechanisms of the Ketogenic Diet. Epilepsia. 2007; 48 (1): 43-58.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Cramer J.A., Mattson R.H., Prevey M.L., Scheyer R.D., Ouellette V.L. How often is medication taken as prescribed? A novel assessment technique. Journal of American Medical Association. 1989 Jun 9; 261 (22): 3273-7.</mixed-citation><mixed-citation xml:lang="en">Cramer J.A., Mattson R.H., Prevey M.L., Scheyer R.D., Ouellette V.L. How often is medication taken as prescribed? A novel assessment technique. Journal of American Medical Association. 1989 Jun 9; 261 (22): 3273-7.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Devinsky O. Patients with Refractory Seizures. New Englang Journal of Medicine 1999; 340: 1565-1570</mixed-citation><mixed-citation xml:lang="en">Devinsky O. Patients with Refractory Seizures. New Englang Journal of Medicine 1999; 340: 1565-1570</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Freeman J., Veggiotti P., Lanzi G., Tagliabue A., Perucca E. The ketogenic diet: from molecular mechanisms to clinical effects. Epilepsy Research. 2006; 68: 145-180.</mixed-citation><mixed-citation xml:lang="en">Freeman J., Veggiotti P., Lanzi G., Tagliabue A., Perucca E. The ketogenic diet: from molecular mechanisms to clinical effects. Epilepsy Research. 2006; 68: 145-180.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">French J.A. Refractory epilepsy: clinical overview. Epilepsia. 2007; 48 (1): 3-7. Review.</mixed-citation><mixed-citation xml:lang="en">French J.A. Refractory epilepsy: clinical overview. Epilepsia. 2007; 48 (1): 3-7. Review.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hermanns G., Noachtar S., Tuxhorn I., Holthausen H., Ebner A., Wolf P. Systematic testing of medical intractability for carbamazepine, phenytoin, and Phenobarbital or primidone in monotherapy for patients considered for epilepsy surgery. Epilepsia. 1996 Jul; 37 (7): 675-9.</mixed-citation><mixed-citation xml:lang="en">Hermanns G., Noachtar S., Tuxhorn I., Holthausen H., Ebner A., Wolf P. Systematic testing of medical intractability for carbamazepine, phenytoin, and Phenobarbital or primidone in monotherapy for patients considered for epilepsy surgery. Epilepsia. 1996 Jul; 37 (7): 675-9.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kwan P., Brodie M.J. Early identification of refractory epilepsy. New Englang Journal of Medicine. 2000 Feb 3; 342 (5): 314-9.</mixed-citation><mixed-citation xml:lang="en">Kwan P., Brodie M.J. Early identification of refractory epilepsy. New Englang Journal of Medicine. 2000 Feb 3; 342 (5): 314-9.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lockard J.S., Congdon W.C., DuCharme L.L. Feasibility and safety of vagal stimulation in monkey model. Epilepsia. 1990; 31: 20-26.</mixed-citation><mixed-citation xml:lang="en">Lockard J.S., Congdon W.C., DuCharme L.L. Feasibility and safety of vagal stimulation in monkey model. Epilepsia. 1990; 31: 20-26.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Loscher W., Potschka H. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. Progress in Neurobiology. 2005, 76: 22-76.</mixed-citation><mixed-citation xml:lang="en">Loscher W., Potschka H. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. Progress in Neurobiology. 2005, 76: 22-76.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Morris A.A. Cerebral ketone body metabolism. Journal of Inherited Metabolic Disease. 2005; 28: 109-121.</mixed-citation><mixed-citation xml:lang="en">Morris A.A. Cerebral ketone body metabolism. Journal of Inherited Metabolic Disease. 2005; 28: 109-121.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Polkey C.E. Clinical outcome of epilepsy surgery. Current Opinion in Neurology. 2004 Apr; 17 (2): 173-8. Review.</mixed-citation><mixed-citation xml:lang="en">Polkey C.E. Clinical outcome of epilepsy surgery. Current Opinion in Neurology. 2004 Apr; 17 (2): 173-8. Review.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt D., Loscher W. Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. Epilepsia. 2005; 46: 858-77.</mixed-citation><mixed-citation xml:lang="en">Schmidt D., Loscher W. Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. Epilepsia. 2005; 46: 858-77.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Shorvon S.D. The epidemiology and treatment of chronic and refractory epilepsy. Epilepsia. 1996; 37 (2): 1-3. Review. PubMed PMID: 8641240.</mixed-citation><mixed-citation xml:lang="en">Shorvon S.D. The epidemiology and treatment of chronic and refractory epilepsy. Epilepsia. 1996; 37 (2): 1-3. Review. PubMed PMID: 8641240.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Tate S.K., Sisodiya S.M. Multidrug resistance in epilepsy: a pharmacogenomic update. Expert Opinion on Pharmacotherapy. 2007; 8: 1441-9.</mixed-citation><mixed-citation xml:lang="en">Tate S.K., Sisodiya S.M. Multidrug resistance in epilepsy: a pharmacogenomic update. Expert Opinion on Pharmacotherapy. 2007; 8: 1441-9.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Vezzani A., French J., Bartfai T., Baram T.Z. The role of inflammation in epilepsy. Nature Reviews Neurology. 2011; 7 (1): 31-40.</mixed-citation><mixed-citation xml:lang="en">Vezzani A., French J., Bartfai T., Baram T.Z. The role of inflammation in epilepsy. Nature Reviews Neurology. 2011; 7 (1): 31-40.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Zabara J. Inhibition of experimental seizures in canines by repetitive vagal stimulation. Epilepsia. 1992; 33: 1005-1012.</mixed-citation><mixed-citation xml:lang="en">Zabara J. Inhibition of experimental seizures in canines by repetitive vagal stimulation. Epilepsia. 1992; 33: 1005-1012.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
